HB3810 - Drug Origin Transparency Act of 2023
US Congress - 118th Congress
Introduced byAnna G. Eshoo, John P. Sarbanes, Angela Dawn Craig
Last updated over 1 year ago
5 Co-Sponsors
To amend the Federal Food, Drug, and Cosmetic Act to enhance drug manufacturing amount information reporting, and for other purposes.
STATUS
Introduced
Verifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity now